OPPapers.com Essay Index >> Miscellaneous >> Cervical Cancer
We have many free term papers and essays on Cervical Cancer. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
cervical cancer. Cervical Cancer 2 Abstract Thousands of women are dieing each year
from cervical caner. ... Cervical Caner 7 References Avera Cancer Institute. ...
A Descriptive Medical Problem: Cervical Cancer. Cancerous ... As a result, cervical
cancer is now the second leading death rate among women. The ...
cervical cancer. Lots of things ... medicine. One of the issues that motivated me
was the research and development of cervical cancer. I, as ...
Cervical Cancer, HPV and HPV Vaccine. ... 4. This HPV test can identify 13 of the
high-risk types of HPV associated with the development of cervical cancer. ...
New Vaccine to Prevent Cervical Cancer: Should it be a mandatory vaccine? New Vaccine
to Prevent Cervical Cancer: Should it be a mandatory vaccination? ...
Submitted by mademan0902 on April 19, 2005
Category: Miscellaneous
Words: 2917 | Pages: 12
Views: 274
Popularity Rank: 33,869
Average Member Grade: N/A (Add a Comment / Grade this Paper)
Cervical cancer is the second foremost occurring cancer in women after breast cancer. Cervical cancer is a sexually transmitted disease caused by the human papillomavirus, or HPV. Infection by HPV typically occurs in the early years of sexual activity according to the World Health Organization (WHO), but it can take up to a full twenty years for it to develop into a full-blown malignant tumor. Scientists believe that for all intents and purposes all cervical cancer cases are caused by infection with a few types of cancer.
Great strides have been made in recent years in the development of a vaccine to treat the cervical cancer. Scientists have cultivated a prophylactic vaccine that would protect against the human papillomavirus. HPV’s role in generating cervical cancer was discovered in 1983. The WHO’s International Agency for Research on Cancer (IARC), located in Lyon, France, has been in the forefront in epidemiological and laboratory studies needed to comprehend the disease. The IARC have chosen different methods, but the origins of most of them are based on genetically engineered Virus Like Particles (VLPs), composed of the outer structural proteins of HPV. These VLPs are not infectious or carcinogenic because they contain no DNA. Some factions are trying to produce the prophylactic vaccine alluded to earlier, while others are developing a therapeutic vaccine for individuals who are already infected. Still others are merging the two techniques. All of approaches have been presented with huge obstacles. Human papillomavirus cannot be replicated in cell culture, nor can it be transmitted to other animals, and human experimentation is limited given the carcinogenic nature of carcinogenic HPV’s that are entirely infectious. All attendees that participated at the WHO conference agreed that because of the diverse dynamic that are potentially at risk of cervical cancer that it is crucial that a prophylactic vaccine be made to targeted at a younger...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!